Hexal Sertralin

Sertralin Hexal is a widely prescribed antidepressant medication containing sertraline hydrochloride. It is manufactured by Hexal AG, one of Germany's leading providers of generic pharmaceuticals. The brand is known for offering high-quality, bioequivalent versions of brand-name medications, making essential treatments more accessible and affordable.

Hexal AG, founded in 1986, is part of the Sandoz group. Sandoz was historically the generics division of the Swiss multinational Novartis. However, in late 2023, Sandoz was successfully spun off as an independent, publicly traded company. Consequently, the ultimate ownership of the Sertralin Hexal brand now lies with Sandoz Group AG, headquartered in Switzerland. Production typically occurs across various European manufacturing sites to ensure a stable supply for the international market.